Assessing the carbon footprint of French academic clinical trials using the NIHR method.

ABSTRACT:

Objectives

This project aimed to assess the applicability of the National Institute for Health and Care Research (NIHR) tool to French academic studies and identify the carbon hotspots, with a view to discussing ways of mitigating their environmental impact.

Design

Retrospective analysis.

Setting

A completed single-centre phase I haematology trial TOCILAM (NCT04547062) and a completed multicentre phase III in intensive care REMICRUSH (NCT03960801).

Participants

TOCILAM had a total number of 12 participants and REMICRUSH had a total number of 1150 participants.

Main outcome measures

Total carbon emissions from each trial and the hotspots of those emissions.

Results

The carbon footprint of the TOCILAM and REMICRUSH studies was estimated at 3.2 and 5

SUBMITTER: Auriault C 

PROVIDER: S-EPMC12742127 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature